Odyssey Health, Inc.
Odyssey Health, Inc.
Your view on ODYY
Overview
What the company does, where it operates, and who runs it.
About Odyssey Health, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Joseph Michael Redmond
- Headquarters
- 2300 West Sahara Avenue, Las Vegas, NV, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Joseph Michael Redmond
- Headquarters
- 2300 West Sahara Avenue, Las Vegas, NV, US
Odyssey Health, Inc., a medical company, focuses on developing medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain disorders.
The company was formerly known as Odyssey Group International, Inc. Odyssey Health, Inc. was founded in 2014 and is based in Las Vegas, Nevada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Odyssey Health, Inc., and the rating behind it. ODYY last traded at $0.06; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Odyssey Health, Inc.. Starting points for Odyssey Health, Inc.: EPS -$0.03, beta -1.25 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Odyssey Health, Inc.. Odyssey Health, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Odyssey Health, Inc.. Trailing twelve-month EPS for Odyssey Health, Inc. stands at -$0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Odyssey Health, Inc.. Odyssey Health, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Odyssey Health, Inc. valued side by side against its closest peers. Odyssey Health, Inc. is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Odyssey Health, Inc., and how their positions are changing. At a $5.5M market value, institutional positions materially move Odyssey Health, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Odyssey Health, Inc. executives and directors. Shares of Odyssey Health, Inc. have traded between $0.0050 and $0.13 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Odyssey Health, Inc.. Odyssey Health, Inc. is a $5.5M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Odyssey Health, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Odyssey Health, Inc.. Coverage tracks Odyssey Health, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.